Effect of raloxifene on arthritis and bone mineral density in rats with collagen-induced arthritis

Calcified Tissue International

Volumn 88, Issue 2, 2011, Pages 87-95

  Hayashi, Ikuta ^a   Hagino, Hiroshi ^a   Okano, Toru ^a   Enokida, Makoto ^a   Teshima, Ryota ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Arthritis; Osteoporosis; Raloxifene; SERM

Indexed keywords

RALOXIFENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DIAPHYSIS; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; FEMUR; METAPHYSIS; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; THICKNESS; TIBIA; TREATMENT RESPONSE;

ANIMALS; ARTHRITIS; ARTHRITIS, EXPERIMENTAL; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; DISEASE MODELS, ANIMAL; FEMALE; RALOXIFENE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79954445983     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-010-9432-6     Document Type: Article

References (33)

1. Saville PD, Kharmosh O (1967) Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids. Arthritis Rheum 10:423-430
2. Da Silva JA, Spector TD (1992) The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin Rheumatol 11:189-194
3. Teshima R, Yamamoto K, Kishimoto H, Morio Y, Hagino H, Maeyama I (1987) Osteoporotic changes in rheumatoid arthritis. J Jpn Orthop Assoc 61:289-297
4. Reid DM, Kennedy NS, Smith MA, Tothill P, Nuki G (1982) Today body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J 285:330-332 (Pubitemid 12085050)
5. Yoshioka T, Hagino H, Yamasaki D, Okano T, Teshima R (2008) Effect of replacement therapy on arthritis and bone mineral density in estrogen-replete rats with collagen-induced arthritis. Mod Rheumatol 18:23-28
6. Maricic M, Adachi JD, Sarkar S, Wu W, Wong M, Harper KD (2002) Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis. Arch Intern Med 162:1140-1143 (Pubitemid 34522401)
7. Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Eastell R et al (2002) Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation Investigators. J Clin Endocrinol Metab 87:3609-3617 (Pubitemid 34879503)
8. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Cummings SR et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) investigators. JAMA 282:637-645 (Pubitemid 29384151)
9. Jochems C, Islander U, Kallkopf A, Lagerquist M, Ohlsson C, Carlsten H (2007) Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis. Arthritis Rheum 56:3261-3270 (Pubitemid 47585421)
10. Esposito E, Iacono A, Raso G, Pacilio M, Coppola A, Meli R et al (2005) Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats. Endocrinology 146:3301-3308 (Pubitemid 41058101)
11. Jochems C, Lagerquist M, Hakansson C, Ohlsson C, Carlsten H (2008) Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis. Clin Exp Immunol 152:593-597 (Pubitemid 351661511)
12. Enokida M, Yamasaki D, Okano T, Hagino H, Morio Y, Teshima R (2001) Bone mass changes of tibial and vertebral bones in young and adult rats with collagen-induced arthritis. Bone 28:87-93 (Pubitemid 32112066)
13. Yamasaki D, Enokida M, Okano T, Hagino H, Teshima R (2001) Effects of ovariectomy and estrogen replacement therapy on arthritis and bone mineral density in rats with collagen-induced arthritis. Bone 28:634-640 (Pubitemid 32577380)
14. Yamane I, Hagino H, Okano T, Enokida M, Yamasaki D, Teshima R (2003) Effect of minodronic acid (ONO-5920) on bone mineral density and arthritis in adult rats with collagen-induced arthritis. Arthritis Rheum 48:1732-1741 (Pubitemid 36682382)
15. Engelhardt G, Homma D, Schnitzler C (1995) Meloxicam: a potent inhibitor of adjuvant arthritis in the Lewis rat. Inflamm Res 44:548-555 (Pubitemid 26008751)
16. Gasser JA (1995) Assessing bone quantity by pQCT. Bone 17 (Suppl): 145S-154S
17. Sato M (1995) Comparative X-ray densitometry of bones from ovariectomized rats. Bone 17 (Suppl): 157S-162S
18. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Recker RR, et al (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595-610
19. Trentham DE, Townes AS, Kang AH (1977) Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 146:857-868 (Pubitemid 8175993)
20. Holmdahl R, Klareskog L, Rubin K (1986) Role of T lymphocytes in murine collagen induced arthritis. Agents Actions 19:295-305 (Pubitemid 17205459)
21. Holmdahl R, Jansson L, Meyerson B (1987) Oestrogen induced suppression of collagen arthritis and decreases the anti type II collagen immune response. Clin Exp Immunol 70:372-378
22. Kramer PR, Kramer SF, Guan G (2004) 17Beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum 50:1967-1975 (Pubitemid 38725109)
23. Ushiyama T, Inoue K, Nishioka J (1995) Expression of estrogen receptor related protein (p29) and estradiol binding in human arthritic synovium. J Rheumatol 22:421-426
24. Guiducci S, Del Rosso A, Cinelli M, Perfetto F, Livi R, Matucci Cerinic M et al (2005) Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. Arthritis Res Ther 7:1244-1253
25. Erlandsson MC, Gomori E, Taube M, Carlsten H (2000) Effects of raloxifene, a selective estrogen receptor modulator, on thymus, T cell reactivity, and inflammation in mice. Cell Immunol 205:103-109 (Pubitemid 32005726)
26. Irie T, Takahata M, Majima T, Abe Y, Komatsu M, Iwasaki N, Minami A (2010) Effect of selective estrogen receptor modulator/raloxifene analogue on proliferation and collagen metabolism of tendon fibroblast. Connect Tissue Res 51:179-187
27. Christgau S, Tankó LB, Cloos PA, Mouritzen U, Christiansen C, Delaissé JM, Høegh-Andersen P (2004) Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM). Menopause 11:508-518 (Pubitemid 40362149)
28. Jansson L, Holmdahl R (1992) Oestrogen-induced suppression of collagen arthritis; 17 beta-oestradiol is therapeutically active in normal and castrated F1 hybrid mice of both sexes. Clin Exp Immunol 89:446-451
29. Ott SM, Oleksik A, Lu Y, Harper K, Lips P (2002) Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women. J Bone Miner Res 17:341-348 (Pubitemid 34087667)
30. Evans GL, Bryant HU, Magee DE, Turner RT (1996) Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia. Endocrinology 137:4139-4144 (Pubitemid 26321858)
31. Evans G, Bryant HU, Magee D, Sato M, Turner RT (1994) The effect of raloxifene on tibia histomorphometry in ovariectomized rats. Endocrinology 134:2283-2288 (Pubitemid 24142974)
32. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Kato S et al (2007) Estrogen prevents bone loss via estrogen receptor a and induction of Fas ligand in osteoclasts. Cell 130:811-823 (Pubitemid 47332572)
33. Cevik R, Em S, Gur A, Nas K, Sarac AJ, Colpan L (2004) Sex and thyroid hormone status in women with rheumatoid arthritis: are there any effects of menopausal state and disease activity on these hormones? Int J Clin Pract 58:327-332 (Pubitemid 38714435)